Related content

Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

By Goto Ayumu   Yamada Yasuhide   Hosokawa Ayumu   Ura Takashi   Arai Tatsuhiro   Hamaguchi Tetsuya   Muro Kei   Shimada Yasuhiro   Shirao Kuniaki  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 364-368

Springer Publishing Company

Access to resources Recommend Favorite

Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR study

By Hebbar Mohamed  

Journal of Chemotherapy, Vol. 25, Iss. 2, 2013-04 ,pp. : 104-111

Maney Publishing

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

By Zori Comba A.   Blajman C.   Richardet E.   Bella S.   Vilanova M.   Coppola F.   Van Kooten M.   Rodger J.   Giglio R.   Balbiani L.   Perazzo F.   Montiel M.   Chacon M.   Pujol F.   Mickiewicz E.   Cazap E.   Recondo G.   Lastiri F.   Simon J.   Wasserman E.   Schmilovich A.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 1006-1013

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusional 5-Fluorouracil (5-FU) and Subcutaneous Interleukin-2 (IL-2) in Metastatic Renal Cancer

By Savage P.   Costelna D.   Moore J.   Gore M.E.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1149-1151

Elsevier

Access to resources Recommend Favorite